The University of Utah’s top-rated physicians and researchers are at the forefront of neuroscience: pioneering treatments in health care, breaking ground in imaging techniques, designing new solutions for brain and spinal cord repair, and more. The Neurosciences Gateway is a portal to discovering more about the U of U’s neuroscience expertise, distributed among many departments, centers, and institutes.
Launched in Fall, 2014, the Neuroscience Initiative unites the academic, translational, and clinical neuroscience communities toward the common goals of better understanding the brain in disease and in health. Learn more.
Upcoming Neuroscience Initiative Events:
Mood & Behavior Disorders Symposium (April 29, 2015, 9:00 AM-2:45 PM): Branch Auditorium, University Neuropsychiatric Institute, 501 Chipeta Way, Salt Lake City UT. Note on parking: Parking is free, but there is no parking in the west lot at the front of the building. Please park in the east lot behind the building.
To RSVP, please fill out this form no later than April 24. Email firstname.lastname@example.org with any questions.
Presentation by Dr. Matthew Anderson, MD, PhD, Harvard Medical School (May 14, 2015; 12:30-1:30 PM):Nucleating a Feisty Autism Gene Network. Health Sciences Education Building Room 1750.
Demyelinating & Neuroimmune Disorders Symposium (June 11, 2015): Health Sciences Education Building Alumni Hall, Salt Lake City UT.
Allen Brain Institute Workshop @ Snowbird (October 31, 2015):Stay tuned for details!
Neuroscience Community Events:
IMFAR Pre-conference (May 13, 2015): Email email@example.com for more information. Little America Hotel, Salt Lake City UT. http://medicine.utah.edu/imfar/index.php. Please note that while the meeting is full, you can still register for FREE streaming access to the pre-conference.
ADD Program Symposium (May 17-19, 2015):Therapy Development in the Era of Team Science & Big Data: What Will the Future Bring to the Patient with Epilepsy? Park City Marriot, Park City UT. http://addsymposium.com/
Neuroscience Initiative Collaborative Pilot Project seed grants: The initiative seeks to further its mission by funding collaborative pilot projects in the neurosciences. Our first call for proposals, due April 17, 2015, can be accessed here and will open starting March 15th on the University of Utah’s CompetitionSpace.
CCTS & Program in Personalized Health Pilot Project grants: The University of Utah's Center for Clinical and Translational Science and the Program in Personalized Health announce a request for proposals for pilot projects describing innovative approaches to personalized health and/or translational research. Grant proposals are due May 29, 2015. Please see CompetitionSpace for more information and to submit.
HHMI, Gates Foundation, & Simons Foundation 2016 Faculty Scholars Competition: A national competition for outstanding scientists. Find the program announcement here.
University of Utah researchers have received $1.4 million to further develop an implantable neural interface that will allow an amputee to move an advanced prosthetic hand with just his or her thoughts. The neural interface will also convey feelings of touch and movement.
Called the Utah Slanted Electrode Array, the neural interface uses 100 electrodes that connect with nerves in an amputee’s arm to read signals from the brain telling the hand how to move. Likewise, the neural interface delivers meaningful sensations of touch and movement from a prosthetic hand back to the brain. READ MORE
Listen to an interview about the research on The Scope Radio.
New Insights Into Causes of ALS
University of Utah neurologists Summer Gibson, M.D., and Stefan Pulst, M.D., are authors on a collaborative, multi-institutional study published in the journal Science. The research identifies mutations in a gene, TBK1, as contributing to ALS. Taken together with previous findings, the discovery highlights defects in biological pathways – autophagy and inflammation - as potential key players in development of the disease.
"This is particularly important because TBK1 is involved in the same natural immunity and autophagy pathways as two other previously identified ALS genes, optineurin (OPTN) and p62 (SQSTM1/sequestosome)," says Gibson. Autophagy in particular may be important for destruction of prion-like structures that accumulate in the brains of some patients. The findings suggest a novel course of therapeutic interventions for treating the disease.